Troluce Capital Advisors LLC Roivant Sciences Ltd. Put Options Transaction History
Troluce Capital Advisors LLC
- $826 Million
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding ROIV
# of Institutions
321Shares Held
497MCall Options Held
1.29MPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$831 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$805 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$777 Million72.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$485 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$412 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.2B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...